Brief: Freeline Reports Updated Data From Phase 1/2 B-Amaze Trial In Hemophilia B

Freeline Therapeutics Holdings

14/12/2020 12:50

Dec 14 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE REPORTS UPDATED DATA FROM PHASE 1/2 B-AMAZE TRIAL
IN
HEMOPHILIA B
    * FREELINE THERAPEUTICS HOLDINGS PLC - UPDATED DOSE-RANGING
DATA
DEMONSTRATE POTENTIAL FOR FULL NORMALIZATION OF FIX ACTIVITY
    * FREELINE THERAPEUTICS HOLDINGS PLC - LONG-TERM FOLLOW UP
DATA
SHOW DURABLE FIX ACTIVITY OUT TO ALMOST 3 YEARS
    * FREELINE THERAPEUTICS HOLDINGS PLC - EXPECTED INITIATION
OF
PIVOTAL PHASE 2B/3 TRIAL PLANNED IN H2 2021

Source text for Eikon:  ID:nGNX1L17PF 
Further company coverage:  FRLN.O 

 ((Reuters.Briefs@thomsonreuters.com;))